J Korean Med Assoc.  2011 Apr;54(4):370-375. 10.5124/jkma.2011.54.4.370.

Depression and suicide

• Jeon HJ

• KMID: 2190417
• DOI: http://doi.org/10.5124/jkma.2011.54.4.370

Abstract

Suicide is the fourth leading cause of death in South Korea, which is the highest rate among the Organization for Economic Cooperation and Development member countries. The World Health Organization worldwide initiative for the prevention of suicide reported that there are at least 20 suicide attempts for every suicide committed. The lifetime prevalence of suicidal ideation, planning, and attempts in South Korea was 15.2%, 3.3%, and 3.2% (single 2.1% and multiple 1.1%), respectively. Suicide attempts showed a significant association with mental disorders, especially major depressive disorder in a Korea-based community study. Brain neuroimaging studies showed prefrontal localized hypofunction and impaired serotonergic responsivity in those attempting suicide, which are also typical findings in patients with depression. Postmortem studies have reported that approximately 60% of suicide victims suffered from major depressive disorder and other mood disorders. Family studies have suggested a genetic linkage between suicide and depression. In conclusion, suicide and suicidal behaviors are significantly associated with depression. Suicide is a medical condition which is treatable and preventable, and suicide rates can be reduced through early diagnosis and treatment for depression. Regular surveys for suicide and depression an essential tool for establishing a national policy for suicide prevention.

Keyword

Suicide; Korea; Depression; Sucide attempt

MeSH Terms

Brain
Cause of Death
Depression
Depressive Disorder, Major
Early Diagnosis
Genetic Linkage
Humans
Korea
Mental Disorders
Mood Disorders
Neuroimaging
Prevalence
Republic of Korea
Suicidal Ideation
Suicide
World Health Organization

Figure

• 

  Figure 1 Suicidal behaviors and issues. ER, emergency room.

• 

  Figure 2 Diagram of lifetime suicidal behaviors of general population in Korea.

Reference

1. World Health Organization. Pharmacological treatment of mental disorders in primary health care. 2009. Geneva: World Health Organization.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 1994. 4th ed. Washington, DC: American Psychiatric Association.

3. Sadock BJ, Kaplan HI, Sadock VA. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 2007. 10th ed. Philadelphia: Lippincott Williams & Wilkins.

4. Lee S, Tsang A, Huang YQ, He YL, Liu ZR, Zhang MY, Shen YC, Kessler RC. The epidemiology of depression in metropolitan China. Psychol Med. 2009. 39:735–747.

5. Brausch AM, Gutierrez PM. Differences in non-suicidal self-injury and suicide attempts in adolescents. J Youth Adolesc. 2010. 39:233–242.

6. Statistics Korea. Death statistics in 2009. 2010. Daejeon: Statistics Korea.

7. Organization for Economic Cooperation and Development. OECD health data 2009: statistics and indicators for 30 countries. 2010. Paris: Organization for Economic Cooperation and Development.

8. World Health Organization. Suicide prevention (SUPRE). 2009. Geneva: World Health Organization.

9. Jeon HJ, Lee JY, Lee YM, Hong JP, Won SH, Cho SJ, Kim JY, Chang SM, Lee D, Lee HW, Cho MJ. Lifetime prevalence and correlates of suicidal ideation, plan, and single and multiple attempts in a Korean nationwide study. J Nerv Ment Dis. 2010. 198:643–646.

10. Jeon HJ, Lee JY, Lee YM, Hong JP, Won SH, Cho SJ, Kim JY, Chang SM, Lee HW, Cho MJ. Unplanned versus planned suicide attempters, precipitants, methods, and an association with mental disorders in a Korea-based community sample. J Affect Disord. 2010. 127:274–280.

11. Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, Bruffaerts R, Chiu WT, de Girolamo G, Gluzman S, de Graaf R, Gureje O, Haro JM, Huang Y, Karam E, Kessler RC, Lepine JP, Levinson D, Medina-Mora ME, Ono Y, Posada-Villa J, Williams D. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008. 192:98–105.

12. Ono Y, Kawakami N, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Tajima M, Takeshima T, Kikkawa T. Prevalence of and risk factors for suicide-related outcomes in the World Health Organization World Mental Health Surveys Japan. Psychiatry Clin Neurosci. 2008. 62:442–449.

13. Joe S, Baser RE, Breeden G, Neighbors HW, Jackson JS. Prevalence of and risk factors for lifetime suicide attempts among blacks in the United States. JAMA. 2006. 296:2112–2123.

14. Cho MJ, Chang SM, Hahm BJ, Chung IW, Bae A, Lee YM, Ahn JH, Won SH, Son J, Hong JP, Bae JN, Lee DW, Cho SJ, Park JI, Lee JY, Kim JY, Jeon HJ, Lee HW. Prevalence and correlates of major mental disorders among Korean adults: a 2006 National Epidemiologic Survey. J Korean Neuropsychiatr Assoc. 2009. 48:143–152.

15. National Institute of Mental Health. A fact sheet of statistics on suicide with information on treatments and suicide prevention. 2010. Bethesda (MD): National Institute of Mental Health.

16. Pandey GN. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann N Y Acad Sci. 1997. 836:182–200.

17. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 2003. 60:14–22.

18. Lesage AD, Boyer R, Grunberg F, Vanier C, Morissette R, Ménard-Buteau C, Loyer M. Suicide and mental disorders: a case-control study of young men. Am J Psychiatry. 1994. 151:1063–1068.

19. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003. 33:395–405.

20. Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsa ET, Kuoppasalmi KI, Lonnqvist JK. Mental disorders and comorbidity in suicide. Am J Psychiatry. 1993. 150:935–940.

21. Kim C, Lesage A, Seguin M, Chawky N, Vanier C, Lipp O, Turecki G. Patterns of co-morbidity in male suicide completers. Psychol Med. 2003. 33:1299–1309.

22. Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, Roy M, Mann JJ, Benkelfat C, Turecki G. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005. 162:2116–2124.

23. Depaulis A, Bandler R, Vergnes M. Characterization of pretentorial periaqueductal gray matter neurons mediating intraspecific defensive behaviors in the rat by microinjections of kainic acid. Brain Res. 1989. 486:121–132.

24. Nierenberg AA, Alpert JE, Gaynes BN, Warden D, Wisniewski SR, Biggs MM, Trivedi MH, Barkin JL, Rush AJ. Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. J Affect Disord. 2008. 108:129–134.

25. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA. 1985. 254:915–918.

26. Jeon HJ, Roh MS, Kim KH, Lee JR, Lee D, Yoon SC, Hahm BJ. Early trauma and lifetime suicidal behavior in a nationwide sample of Korean medical students. J Affect Disord. 2009. 119:210–214.

27. Medication guide antidepressant medicines, depression and other serious men-tal illnesses, and suicidal thoughts or actions [Internet]. U.S. Food and Drug Administration. 2008. cited 2011 Mar 16. Silver Spring (MD): U.S. Food and Drug Administration;Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089832.pdf.

28. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009. 70:1069–1077.